Artificial Tissue Market Growth and Technology Advancement Outlook in Healthcare Sector 2021-2030

Artificial tissue is prepared in labs but exhibits property of a live tissue, thus it is used as a substitute of a natural tissue. Fabrication of artificial tissue is done with help of numerous bio-fabrication techniques. The main advantage associated with the deployment of artificial tissue is its ability to provide growth factor near the wound site, where it is planted. Artificial tissue is currently seen as a promising field of medical research and bio-technology. With increasing popularity of artificial tissues embedded in artificial organs, demand for artificial tissue is expected to grow significantly during the forecast period, backed by advancing application of AI in medical sciences. This impressive growth rate is also facilitated by ascending application of 3D printing in healthcare industry. 3D bio-printing has made it possible to develop vascularized tissue, which are nearly 10-fold thicker and is composed of live human cells.

Access Full Description of this report at:-

https://www.nextmsc.com/report/artificial-tissue-market

Competitive Landscape

The artificial tissue market is comprising of various market players such as Tissue Regenix Group plc, Baxter International, Inc., Integra LifeSciences Corporation, Allergen Plc., Zimmer Biomet Holdings, Inc., Becton, Dickinson and Company, Wright Medical Group, Taxus Cardium Pharmaceuticals, American CryoStem and Asterias Biotherapeutics. Key players in the market are focusing towards continuous product innovation, with investing higher amount in R&D activity. For instance, university at Buffalo Research has introduced creating three-dimensional artificial tissue, with an objective of advancement that could improve experimental drug testing, the quality of artificial organs.

Moreover, in September, 2020, Rice and the University of Washington (UW) have announced their initial investment strategy to remotely control cell functions of 3D build artificial tissues. These remote technologies will further help in controlling positioning and timing of the tissues.

Market Dynamics and Trends

A meteoric surge has been observed in the advancement of medical science with a blend of rising awareness with regards to organ transplantation. According to the data released by the U.S. government in September 2019, more than 1,20,000 patients are queued for organ transplantation and each 10 minutes a new patient is added to the list. This is likely to strengthen the demand for artificial tissue over the next decade.

Over the last half decade, 3D bio printing has made its space in organ and tissue transplantation and has proven to be crucial. This technology is massively utilized in the development of artificial tissue. 3D bio printing is gaining momentum due to its advantage of getting less rejection by human body. Further, integration of artificial intelligence in the fabrication of artificial tissue is poised to drive the growth trend of the market.

However, unprecedented event of Covid-19 has brutally impacted multiple sectors across multitude avenues resulting to flatten the global economy curve. Due to the pandemic, artificial tissue market has seen a moderate fall due to the increased involvement of medical facilities towards Covid patients and limited manufacturing capacity owing to lockdowns and social distancing measures. Further, the decision of patient to postpone the transplantation considering the spread of the virus at a global scale has restricted the growth of market.

Request sample copy of this report at:-

https://www.nextmsc.com/artificial-tissue-market/request-sample

Geographical Analysis

North America is expected to dominate global artificial tissue market throughout the forecast period (2022-2030). This is because the U.S. has the highest organ transplant demand in the world. In 2019, there was around 123 per million people, who undergo transplants. However, Europe is expected to gain higher traction than the global average. This is attributed to higher transplant rate in Spain and France, which are 117 and 90 per million people respectively. Also, greater number of old-age population and increasing expenditure towards skin and bone treatment would further pave path for skin tissue and bone tissue-based markets in the region.

On the other hand, Asia Pacific is seen as emerging market for artificial owing to increasing investment by key players and advancing demand from patients. China holds maximum amount of market share in Asia-Pacific region. This is attributed to increasing use of 3D bio-printing in healthcare domain.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.